Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Beh çet's Disease

To assess efficacy, safety, and cost-effectiveness of adalimumab (ADA) therapy optimization in a large series of patients with uveitis due to Beh çet disease (BD) who achieved remission after the use of this biologic agent.

Source: Ophthalmology - March 27, 2018 Category: Opthalmology Authors: Jos é Luis Martín-Varillas, Vanesa Calvo-Río, Emma Beltrán, Juan Sánchez-Bursón, Marina Mesquida, Alfredo Adán, María Victoria Hernandez, Marisa Hernández Garfella, Elia Valls Pascual, Lucía Martínez-Costa, Agustí Sellas-Fernández, Miguel Cor Source Type: research